UMGWi004-B-3
General
iPSC Line |
|
| hPSCreg name | UMGWi004-B-3 |
| Cite as: | UMGWi004-B-3 |
| iPSC line type | Human induced pluripotent stem cell (hiPSC) |
| Similar iPSC lines |
UMGWi004-B (BNH1 _iPSC_WT_48) UMGWi004-B-1 (BNH1_iPSC_FHS1_cr_well7_JR) UMGWi004-B-2 (BNH1_iPSC_FHS1_cr_well12_JR) UMGWi004-A (BNH1 _iPSC_WT_8) |
| Last update | 9th April 2026 |
| User feedback | |
Provider |
|
| Generator | Department of Functional Genomics - Human Molecular Genetics (UMGW) |
External iPSC Databases |
|
| BioSamples | SAMEA120796679 |
General iPSC Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
iPSC Genetic Modification
| Disease/phenotype related modifications |
|
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
| All cell lines of this donor's relatives |
Has son:
|
External Databases (Donor) |
|
| BioSamples | SAMEA115116692 |
Ethics
Also have a look at the ethics information for the parental line
UMGWi004-B
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
| Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No |
iPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
UMGWi004-B.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Episomal |
| Genes | |
| Is reprogramming vector detectable? |
No |
| Methods used |
PCR
|
| Notes on reprogramming vector detection | No residual vector through PCR of EBNA1 and OriP in the iPSC detected |
| Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming |
|
Other |
|
| Selection criteria for clones | Sanger sequencing of the target regions and visual inspection of the corresponding chromatograms using the online tool Benchling (www.benchling.org) |
| Derived under xeno-free conditions |
No |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
iPSC Culture Conditions
| Surface coating | Matrigel/Geltrex | ||||||
| Feeder cells |
No |
||||||
| Passage method | Mechanically | ||||||
| CO2 Concentration | 5 % | ||||||
| Medium |
mTeSR™ 1
Supplements
|
||||||
| Has Rock inhibitor (Y27632) been used at passage previously with this iPSC line? | No |
||||||
| Has Rock inhibitor (Y27632) been used at cryo previously with this iPSC line? | No |
||||||
| Has Rock inhibitor (Y27632) been used at thaw previously with this iPSC line? | Yes |
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| SOX2 |
Yes |
|||||
| TRA 1-60 |
Yes |
|||||
| POU5F1 (OCT-4) |
Yes |
|||||
| NANOG |
Yes |
Morphology pictures
Differentiation Potency
In vitro spontaneous differentiation
Morphology
In vitro spontaneous differentiation
Morphology
Alexa 555
Alexa 488
In vitro spontaneous differentiation
Morphology
Microbiology / Virus Screening |
|
| Mycoplasma | Negative |
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
46,XY
Passage number: 4
Karyotyping method:
low-coverage whole genome sequencing (lcWGS)
|
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.